United States · FDA National Drug Code directory
Ranolazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27241-126_933f695e-e4f4-4c75-80fc-aea9a30aa13d
- Product NDC
- 27241-126
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Ranolazine
- Labeler
- Ajanta Pharma USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190823
- Source listing expiry
- 20261231
Source-listed ingredients
- RANOLAZINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-02) · 27241-126-02
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-05) · 27241-126-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →